Cochrane Abstracts
Beginning reading interventions for children and adolescents with intellectual disability
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Beginning Reading Interventions for Children and Adolescents With Intellectual Disability." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437217/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review. Accessed 16 April 2024.
Beginning reading interventions for children and adolescents with intellectual disability. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437217/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review. Accessed April 16, 2024.
Beginning reading interventions for children and adolescents with intellectual disability. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437217/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review
Beginning Reading Interventions for Children and Adolescents With Intellectual Disability [Internet]. In: Cochrane Abstracts. [cited 2024 April 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437217/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Beginning reading interventions for children and adolescents with intellectual disability
ID - 437217
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437217/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
